![Katie Peng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katie Peng
Directeur/Membre du Conseil chez
SCHOLAR ROCK HOLDING CORPORATION
Fortune : 2 M $ au 30/06/2026
Profil
Ms. Katie Peng is an Independent Director at Scholar Rock Holding Corp., an Independent Director at Adicet Bio, Inc. and a Chief Commercial Officer at Denali Therapeutics, Inc. She is on the Board of Directors at Scholar Rock Holding Corp., Adicet Bio, Inc. and California Life Sciences Association.
Ms. Peng was previously employed as a General Manager by Roche Products Ltd. (Taiwan), a General Manager by Roche Singapore Pte Ltd., and a Senior Vice President & Head-OMNI Business Unit by Genentech, Inc. She received her undergraduate degree from the University of California, Berkeley and an MBA from Kelley School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/07/2026 | 34 301 ( 0,03% ) | 2 M $ | 30/06/2026 | |
| 21/06/2026 | 368 ( 0% ) | 3 180 $ | 30/06/2026 |
Postes actifs de Katie Peng
| Sociétés | Poste | Début |
|---|---|---|
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 27/09/2021 |
| ADICET BIO, INC. | Directeur/Membre du Conseil | 10/07/2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Directeur/Membre du Conseil | 15/02/2024 |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Directeur/Membre du Conseil | - |
Anciens postes connus de Katie Peng
| Sociétés | Poste | Fin |
|---|---|---|
Roche Products Ltd. (Taiwan) | Directeur Général | 01/03/2017 |
Roche Singapore Pte Ltd.
 Roche Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops new medicines and diagnostics solutions | Directeur Général | 01/03/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Formation de Katie Peng
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
16
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Singapore Pte Ltd.
Roche Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops new medicines and diagnostics solutions | Health Technology |
Roche Products Ltd. (Taiwan) | |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Adicet Bio, Inc.
 Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
